The Genomic Signatures of Linitis Plastica Signal the Entrance into a New Era: Novel Approaches for Diagnosis and Treatment

被引:0
|
作者
Christodoulidis, Grigorios [1 ]
Koumarelas, Konstantinos Eleftherios [1 ]
Kouliou, Marina Nektaria [1 ]
Samara, Maria [2 ]
Thodou, Eleni [2 ]
Zacharoulis, Dimitris [1 ]
机构
[1] Univ Thessaly, Univ Hosp Larissa, Dept Gen Surg, Biopolis Campus, Larisa 41110, Greece
[2] Univ Thessaly, Fac Med, Sch Hlth Sci, Dept Pathol, Biopolis Campus, Larisa 41110, Greece
关键词
Linitis Plastica; Borrmann type IV; oncogenes in LP; biomarkers; targeting agents; surgery; GASTRIC-CANCER; FIBROBLASTS; EXPRESSION; EFFICACY;
D O I
10.3390/ijms241914680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Linitis Plastica (LP) is a rare and aggressive tumor with a distinctive development pattern, leading to the infiltration of the gastric wall, the thickening of the gastric folds and a "leather bottle appearance". LP is an extremely heterogeneous tumor caused by mutations in oncogenic and tumor suppressive genes, as well as molecular pathways, along with mutations in stromal cells and proteins related to tight junctions. Elucidating the molecular background of tumorigenesis and clarifying the correlation between cancerous cells and stromal cells are crucial steps toward discovering novel diagnostic methods, biomarkers and therapeutic targets/agents. Surgery plays a pivotal role in LP management, serving both as a palliative and curative procedure. In this comprehensive review, we aim to present all recent data on the molecular background of LP and the novel approaches to its management.
引用
收藏
页数:12
相关论文
共 9 条
  • [1] Genomic Imprinting in the New Omics Era: A Model for Systems-Level Approaches
    Hubert, Jean-Noel
    Demars, Julie
    FRONTIERS IN GENETICS, 2022, 13
  • [2] New Approaches to the Diagnosis and Treatment of Learning Disabilities in an International Context
    Alahmadi, Nsreen
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2016, 27 (04) : 265 - 271
  • [3] Prognostic and Predictive Factors in Patients With Chronic Lymphocytic Leukemia: Relevant in the Era of Novel Treatment Approaches?
    Mertens, Daniel
    Stilgenbauer, Stephan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : 869 - 872
  • [4] Inference of Developmental Gene Regulatory Networks Beyond Classical Model Systems: New Approaches in the Post-genomic Era
    Fernandez-Valverde, Selene L.
    Aguilera, Felipe
    Alexander Ramos-Diaz, Rene
    INTEGRATIVE AND COMPARATIVE BIOLOGY, 2018, 58 (04) : 640 - 653
  • [5] Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
    Li, Jing
    Zhang, Yingjie
    Sun, Fenghao
    Xing, Ligang
    Sun, Xiaorong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [6] New therapeutic approaches in the treatment of anogenital lichen sclerosus: does photodynamic therapy represent a novel option?
    Criscuolo, Anna A.
    Schipani, Caterina
    Cannizzaro, Maria V.
    Messinese, Serena
    Chimenti, Sergio
    Piccione, Emilio
    Saraceno, Rosita
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2017, 152 (02): : 117 - 121
  • [7] Diagnosis and first-line treatment of non-small cell lung cancer in the era of novel immunotherapy: recommendations for clinical practice
    De Marinis, Filippo
    Barberis, Massimo
    Barbieri, Vito
    Marchiano, Alfonso
    Gasparini, Stefano
    Migliorino, Maria Rita
    Romano, Giampiero
    Spinnato, Francesca
    Vitiello, Fabiana
    Gridelli, Cesare
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (03) : 217 - 228
  • [8] Identification of novel immune-related signatures for keloid diagnosis and treatment: insights from integrated bulk RNA-seq and scRNA-seq analysis
    Xiao, Kui
    Wang, Sisi
    Chen, Wenxin
    Hu, Yiping
    Chen, Ziang
    Liu, Peng
    Zhang, Jinli
    Chen, Bin
    Zhang, Zhi
    Li, Xiaojian
    HUMAN GENOMICS, 2024, 18 (01)
  • [9] Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification
    Lyu, Fang
    Li, Yunxue
    Yan, Zhecheng
    He, Qingliu
    Cheng, Lulin
    Zhang, Pu
    Liu, Bing
    Liu, Chunyu
    Song, Yarong
    Xing, Yifei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)